Skip to main content

Articles

Page 11 of 16

  9. About 5-10% of breast and ovarian carcinomas are hereditary and most of these result from germline mutations in the BRCA1 and BRCA2 genes. In women of Ashkenazi Jewish ascendance, up to 30% of breast and ovarian ...

    Authors: Ingrid P Ewald, Patrícia Izetti, Fernando R Vargas, Miguel AM Moreira, Aline S Moreira, Carlos A Moreira-Filho, Danielle R Cunha, Sara Hamaguchi, Suzi A Camey, Aishameriane Schmidt, Maira Caleffi, Patrícia Koehler-Santos, Roberto Giugliani and Patricia Ashton-Prolla
    Citation: Hereditary Cancer in Clinical Practice 2011 9:12
    Content type: Research Published on:

  10. We assessed ovarian cancer screening outcomes in women with a positive family history of ovarian cancer divided into a low-, moderate- or high-risk group for development of ovarian cancer.

    Authors: Marielle AE Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, Fiona Lennard, Paul Pharoah, Ian Jacobs, Ann Ward, Desmond PJ Barton, Thomas EJ Ind, John H Shepherd, Jane E Bridges, Martin Gore, Chris Haracopos, Susan Shanley, Audrey Ardern-Jones, Sarah Thomas…
    Citation: Hereditary Cancer in Clinical Practice 2011 9:11
    Content type: Research Published on:

  11. Inheritance of a mutation in either BRCA1 or BRCA2 accounts for approximately 5% of all breast cancer cases, but varies by country. Investigations into the contribution of BRCA mutations to breast cancer incidenc...

    Authors: Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang, Steven A Narod and Joanne Kotsopoulos
    Citation: Hereditary Cancer in Clinical Practice 2011 9:10
    Content type: Research Published on:

  12. Perforin gene (PRF1) mutations have been identified in some patients diagnosed with the familial form of hemophagocytic lymphohistiocytosis (HLH) and in patients with lymphoma. The aim of the present study was to...

    Authors: Rim El Abed, Violaine Bourdon, Ilia Voskoboinik, Halima Omri, Yosra Ben Youssef, Mohamed Adnene Laatiri, Laetitia Huiart, François Eisinger, Laetitia Rabayrol, Marc Frenay, Paul Gesta, Liliane Demange, Hélène Dreyfus, Valérie Bonadona, Catherine Dugast, Hélène Zattara…
    Citation: Hereditary Cancer in Clinical Practice 2011 9:9
    Content type: Research Published on:

  13. Lynch syndrome is a hereditary cancer with confirmed carriers at high risk for colorectal (CRC) and extracolonic cancers. The purpose of the current study was to develop a greater understanding of the factors ...

    Authors: Kathy E Watkins, Christine Y Way, Jacqueline J Fiander, Robert J Meadus, Mary Jane Esplen, Jane S Green, Valerie C Ludlow, Holly A Etchegary and Patrick S Parfrey
    Citation: Hereditary Cancer in Clinical Practice 2011 9:8
    Content type: Research Published on:

  14. The perception of breast cancer risk held by women who have not had breast cancer, and who are at increased, but unexplained, familial risk of breast cancer is poorly described. This study aims to describe ris...

    Authors: Louise A Keogh, Belinda J McClaren, Carmel Apicella and John L Hopper
    Citation: Hereditary Cancer in Clinical Practice 2011 9:7
    Content type: Research Published on:

  15. Neurofibroma occurs as isolated or multiple lesions frequently associated with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder affecting 1 in 3500 individuals. It is caused by mutations in...

    Authors: Giovanni Ponti, Lorena Losi, Davide Martorana, Manuela Priola, Elisa Boni, Annamaria Pollio, Tauro Maria Neri and Stefania Seidenari
    Citation: Hereditary Cancer in Clinical Practice 2011 9:6
    Content type: Research Published on:

  16. Tumors arising in patients with hereditary cancer syndromes may have distinct drug sensitivity as compared to their sporadic counterparts. Breast and ovarian neoplasms from BRCA1 or BRCA2 mutation carriers are ch...

    Authors: Evgeny N Imyanitov and Vladimir M Moiseyenko
    Citation: Hereditary Cancer in Clinical Practice 2011 9:5
    Content type: Review Published on:

  17. Risk perception is considered a motivating factor for adopting preventive behaviors. This study aimed to verify the demographic characteristics and cancer family history that are predictors of risk perception ...

    Authors: Erika M Santos, Maria TC Lourenço and Benedito M Rossi
    Citation: Hereditary Cancer in Clinical Practice 2011 9:4
    Content type: Research Published on:

  18. The BRCA1/2 genes account for a significant portion of hereditary breast and ovarian cancers and they are especially prevalent in the Ashkenazi Jewish population. Women who have a mutation can prevent breast a...

    Authors: Katherine H Saunders, Shivani Nazareth and Peter I Pressman
    Citation: Hereditary Cancer in Clinical Practice 2011 9:3
    Content type: Case report Published on:

  31. Patients at higher than average risk of heritable cancer may process risk information differently than the general population. However, little is known about clinical, demographic, or psychosocial predictors t...

    Authors: Jon C Tilburt, Katherine M James, Pamela S Sinicrope, David T Eton, Brian A Costello, Jantey Carey, Melanie A Lane, Shawna L Ehlers, Patricia J Erwin, Katherine E Nowakowski and Mohammad H Murad
    Citation: Hereditary Cancer in Clinical Practice 2011 9:2
    Content type: Research Published on:

  32. Carcinomas of the appendix are exceedingly rare tumors and have an annual age-adjusted incidence of around 0.4 cases per 100,000. Appendiceal adenocarcinoma accounts for < 0.5% of all gastrointestinal neoplasm...

    Authors: Adrianne R Racek, Kari G Rabe, Myra J Wick, Apostolos Psychogios and Noralane M Lindor
    Citation: Hereditary Cancer in Clinical Practice 2011 9:1
    Content type: Case report Published on:
Submit manuscript

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    1.7 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    0.634 - SNIP (Source Normalized Impact per Paper)
    0.526 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    394,813 downloads
    196 Altmetric mentions

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287